Your browser doesn't support javascript.
loading
Potential for Tight Junction Protein-Directed Drug Development Using Claudin Binders and Angubindin-1.
Hashimoto, Yosuke; Tachibana, Keisuke; Krug, Susanne M; Kunisawa, Jun; Fromm, Michael; Kondoh, Masuo.
Affiliation
  • Hashimoto Y; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Tachibana K; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Krug SM; Institute of Clinical Physiology, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.
  • Kunisawa J; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Fromm M; Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
  • Kondoh M; International Research and Development Center for Mucosal Vaccines, The Institute of Medical Sciences, The University of Tokyo, Tokyo 108-8639, Japan.
Int J Mol Sci ; 20(16)2019 Aug 17.
Article in En | MEDLINE | ID: mdl-31426497
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tight Junctions / Tight Junction Proteins / Drug Development Limits: Animals / Humans Language: En Journal: Int J Mol Sci Year: 2019 Document type: Article Affiliation country: Japan Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tight Junctions / Tight Junction Proteins / Drug Development Limits: Animals / Humans Language: En Journal: Int J Mol Sci Year: 2019 Document type: Article Affiliation country: Japan Country of publication: Switzerland